In recent years, the international debate on drug policy reform has intensified, and with it has come a productive exchange of information between academics, activists and advocates on the diverse mo ...

At a time of increased debate on the laws controlling the use of cannabis in the European Union, this report answers some of the questions most often asked about cannabis legislation. Using a questio ...

The 2016 EU Drug Markets Report provides a unique insight into the operation of illicit drug markets in the EU. The report assesses the impact of the drug market on society and the factors driving it ...

While in the Americas cannabis policy reform is taking off, Europe seems to be lagging behind. That is to say, in European nations at the level of national governments – where denial of the changing ...

The UK and the Netherlands commissioned distinguished scholars and experts to study the social and clinical harms of khat. These experts argued that any harms associated with khat did not require a c ...

The expert seminar “Where next for Europe on drug policy reform?” analysed the new EU strategy on drugs and its action plan and discussed ways to improve and innovate European drug policy. The semina ...

The seminar entitled “Modernising the global drug control system – Can Europe lead?” was organised in the European Parliament by the International Drug Policy Consortium (IDPC), and the Global Commis ...

In recent years of global debate on policies and strategies on controlled drugs, the European institutions (European Commission and Council, and the EMCDDA) and member states have broadly been a prog ...

With the Lisbon Treaty now in place, the European response to drugs needs to be strong and decisive, addressing both drug demand and drug supply. New legislation involving the European Parliament, an ...

The main purpose of this evaluation was to determine to what extent the principal goal of Dutch drug policy has been achieved, as stated in the 1995 Policy Document on Drugs (Drugsnota). This asserts ...